0000000000424318

AUTHOR

Laura Righetti

0000-0003-4238-0665

showing 2 related works from this author

Metabolomic Changes after Coffee Consumption: New Paths on the Block

2021

Scope Several studies suggest that regular coffee consumption may help preventing chronic diseases, but the impact of daily intake and the contribution of coffee metabolites in disease prevention are still unclear. The present study aimed at evaluating whether and how different patterns of coffee intake (one cup of espresso coffee/day, three cups of espresso coffee/day, one cup of espresso coffee/day and two cocoa-based products containing coffee two times per day) might impact endogenous molecular pathways. Methods and results A three-arm, randomized, cross-over trial was performed in 21 healthy volunteers who consumed each treatment for one month. Urine samples were collected to perform u…

AdultMale0301 basic medicineEndocrinology Diabetes and MetabolismcoffeeEnergy metabolismMedicine (miscellaneous)030209 endocrinology & metabolismCoffee consumptionParallel computingUrine030204 cardiovascular system & hematologyBiology03 medical and health sciences0302 clinical medicineMetabolomicsArginine biosynthesisBlock (telecommunications)CaffeineCoffee intakeHumansxenobioticsFood scienceAmino AcidsMathematicsCacaoNutrition and Dietetics030109 nutrition & dieteticsDose-Response Relationship Drugmetabolomics3. Good healthMetabolic pathway030104 developmental biologycocoabiomarkerFemaleSteroidsDisease preventionCardiology and Cardiovascular Medicine[SDV.AEN]Life Sciences [q-bio]/Food and NutritionBiomarkersMetabolic Networks and PathwaysFood ScienceBiotechnology
researchProduct

Investigating the in vitro catabolic fate of Enniatin B in a human gastrointestinal and colonic model

2019

Abstract Enniatin B is an emerging mycotoxin known to present biological activity because of its ionophoric characteristics. This compound has demonstrated strong in vitro cytotoxicity against different cancer cells, also at low molecular concentrations. Its natural occurrence in food commodities and feed is highly reported world-wide, but few information is available about its stability in the human gastro-intestinal tract. The present work evaluates the catabolic fate of enniatin B upon in vitro simulated digestion and colonic fermentation. LC-MS target and untargeted analysis have been performed to quantify the extent of enniatin B degradation and the formation of catabolic products. The…

ColonIn silicoToxicologyModels BiologicalFeces03 medical and health scienceschemistry.chemical_compound0404 agricultural biotechnologyDepsipeptidesHumansMycotoxin030304 developmental biologyDepsipeptide0303 health sciencesGastrointestinal tractCatabolismBiological activity04 agricultural and veterinary sciencesGeneral MedicineMycotoxins040401 food scienceIn vitroGastrointestinal MicrobiomeGastrointestinal TractchemistryBiochemistryFermentationDigestionFood ScienceFood and Chemical Toxicology
researchProduct